Literature DB >> 17932759

Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study.

Hyun Joo Jang1, Min Ho Choi, Woon Geon Shin, Kyung Ho Kim, Yong Woo Chung, Kyoung Oh Kim, Cheol Hee Park, Il Hyun Baek, Kwang Ho Baik, Sea Hyub Kae, Hak Yang Kim.   

Abstract

BACKGROUND: The incidence of H. pylori-negative, idiopathic peptic ulcer disease (IPUD) seems to be increasing with the changing trends of PUD and H. pylori infection in some developed countries. AIM: To investigate the changing trend of PUD and the prevalence ofH. pylori infection during the last decade and the prevalence of IPUD in Korea.
METHODS: We prospectively evaluated H. pylori infection and the characteristics of PUD in 895 patients with newly diagnosed PUD from September 2004 to February 2005.
RESULTS: The H. pylori infection rate in PUD was 72.0% and the proportion of IPUD was 22.2%. The proportion of gastric ulcer (GU) has significantly increased (47.8% vs. 44.3%) and the proportion of duodenal ulcer (DU) has significantly decreased (38.9% vs. 44.9%) compared with ten years ago. The changing trend in the prevalence of H. pylori infection in GU and DU showed an increase in GU (66.1% vs. 73.1%, P = 0.014) and a decrease in DU (79.3% vs. 68.1%, P = 0.001).
CONCLUSION: Compared with our results of ten years ago, there has been a significant change in the distribution of PUD and in the prevalence of H. pylori infection in GU and DU. Patients with IPUD are not uncommon in Korea.

Entities:  

Mesh:

Year:  2008        PMID: 17932759     DOI: 10.1007/s10620-007-0028-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.

Authors:  J H Kurata; A N Nogawa
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

3.  Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated.

Authors:  A A Ciociola; D J McSorley; K Turner; D Sykes; J B Palmer
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

4.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.

Authors:  S Derry; Y K Loke
Journal:  BMJ       Date:  2000-11-11

5.  Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.

Authors:  C Vu; Y Y Ng
Journal:  Singapore Med J       Date:  2000-10       Impact factor: 1.858

Review 6.  The prevalence of Helicobacter pylori in peptic ulcer disease.

Authors:  E J Kuipers; J C Thijs; H P Festen
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

7.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

Review 8.  Peptic-ulcer disease.

Authors:  Francis K L Chan; W K Leung
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

9.  Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.

Authors:  L Laine; M Marin-Sorensen; W M Weinstein
Journal:  Am J Gastroenterol       Date:  1992-10       Impact factor: 10.864

10.  The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.

Authors:  M Teresa Arroyo; Montse Forne; Carlos Martin de Argila; Faust Feu; Juan Arenas; Juan de la Vega; Vicente Garrigues; Francisco Mora; Manuel Castro; Luis Bujanda; Angel Cosme; Agustín Castiella; Javier P Gisbert; Antonio Hervas; Angel Lanas
Journal:  Helicobacter       Date:  2004-06       Impact factor: 5.753

View more
  15 in total

1.  Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.

Authors:  Kae Sugawara; Shigeto Koizumi; Yohei Horikawa; Nobuya Mimori; Tsuyotoshi Tsuji; Hajime Ishii; Shusei Fujimori; Kengo Onochi; Hiroyuki Watanabe; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

Review 2.  Burden of Gastroduodenal Diseases from the Global Perspective.

Authors:  Vladimir Milivojevic; Tomica Milosavljevic
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-28

3.  Time trends in epidemiology of peptic ulcer disease in India over two decades.

Authors:  Amit Kumar Dutta; Ashok Chacko; Avinash Balekuduru; Manoj Kumar Sahu; Sajith Kattiparambil Gangadharan
Journal:  Indian J Gastroenterol       Date:  2012-07-06

Review 4.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

5.  Efficacy of Zinc Sulfate in Peptic Ulcer Disease: A Randomized Double-Blind Clinical Trial Study.

Authors:  Kambiz Yazdanpanah; Baran Parhizkar; Farshad Sheikhesmaeili; Mohammad Roshani; Morteza Nayebi; Fardin Gharibi
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 6.  Quality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance.

Authors:  Tetsuo Arakawa; Toshio Watanabe; Tetsuya Tanigawa; Kazunari Tominaga; Yasuhiro Fujiwara; Ken'ichi Morimoto
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 7.  Therapeutic management of recurrent peptic ulcer disease.

Authors:  Raymond S Tang; Francis K L Chan
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

8.  Molecular docking, synthesis, kinetics study, structure-activity relationship and ADMET analysis of morin analogous as Helicobacter pylori urease inhibitors.

Authors:  Ritu Kataria; Anurag Khatkar
Journal:  BMC Chem       Date:  2019-04-01

9.  High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up.

Authors:  Hyuk Yoon; Sang Gyun Kim; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2013-03-14       Impact factor: 4.519

10.  Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin.

Authors:  Hyun Jin Song; Jin-Won Kwon; Nayoung Kim; Young Soo Park
Journal:  Gut Liver       Date:  2013-03-14       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.